Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|7|599-610

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.7, 2009-01, pp. : 599-610

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1115-1120

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care

By Pettengell Ruth  

Clinical Drug Investigation, Vol. 29, Iss. 8, 2009-08 ,pp. : 491-513

Adis International

Access to resources Recommend Favorite

Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited

By Calhoun Elizabeth A.  

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 767-775

Adis International

Access to resources Recommend Favorite

Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia

By Esser M.   Brunner H.  

PharmacoEconomics, Vol. 21, Iss. 18, 2003-01 ,pp. : 1295-1313

Adis International

Access to resources Recommend Favorite

Granulocyte-macrophage colony-stimulating factor enhances interleukin-1 stimulated histamine release in the preovulatory rat ovary

By Tamura K.   Kogo H.  

European Journal of Pharmacology, Vol. 373, Iss. 2, 1999-06 ,pp. : 207-213

Elsevier

Access to resources Recommend Favorite